☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Bayer Entered into an Option Agreement with Mammoth Biosciences to Develop Novel Gene Editing Technology
January 10, 2022
Novartis and Molecular Partners Reports Results of Ensovibep (MP0420) in P-II (EMPATHY) Clinical Trial for the Treatment of COVID-...
January 10, 2022
Biohaven Entered into an Exclusive License and Research Agreement with KU Leuven to Develop and Commercialize BHV-2100 for Chronic...
January 10, 2022
Amgen’s Lumykras (sotorasib) Receives EC’s Approval for the Treatment of Non-Small Cell Lung Cancer
January 10, 2022
AbbVie Submits Application to US FDA and EMA for Rinvoq (upadacitinib) to Treat Non-Radiographic Axial Spondyloarthritis
January 10, 2022
JAMP and Alvotech’s Simlandi (biosimilar, adalimumab) Receive Health Canada’s Approval for the Treatment of Inflammatory Diseases
January 10, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions